ÂÜÀòÂÒÂ×

Dr. Cornelia Jäkel began their work experience in 2013 as a PhD student at the dkfz - German Cancer Research Center, where they focused on Molecular Medicine and achieved a magna cum laude (1,0) distinction. Dr. Cornelia transitioned to the National Center for Tumor Diseases (NCT) Heidelberg in 2017, initially working as a Clinical Trial Coordinator/Research Associate. In April 2018, they were promoted to the role of Head of Clinical Trial Office RadioOncology.

Dr. Cornelia Jäkel began their education at FAU Erlangen-Nürnberg, where they obtained a Bachelor of Science (BS) degree in Molecular Medicine from 2008 to 2011. Dr. Cornelia further pursued their studies in the same field at both FAU Erlangen-Nürnberg and The Johns Hopkins University, earning a Master of Science (MS) degree from both institutions. Dr. Cornelia attended FAU Erlangen-Nürnberg from 2011 to 2013 and The Johns Hopkins University from 2012 to 2013.

In addition to their academic achievements, Dr. Jäkel also obtained certifications in business-related areas. In 2015, they obtained the international Certificate for Business Competence (EBC*L) Level A, specializing in Business Objectives and Management Ratios, Accounting, Costing and Pricing, and Business Law. Furthermore, in 2016, Dr. Jäkel acquired the international Certificate for Business Competence (EBC*L) Level B, focusing on Business Plan, Marketing and Sales, Investment Analysis, Financial Planning, and Financing.